Elucent Medical Secures Series C Funding to Advance Oncologic Surgery Innovation Elucent Medical announces the successful closure of its $42.5 million Series C funding round.

Elucent Announces New Partnership With SurvivingBreastCancer.org EDEN PRAIRIE, Minn., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Elucent Medical, a pioneering medical device company specializing in developing innovative solutions for sensitive cancer screening techniques...

Elucent Announces Key Executive Appointments to Chief Executive Officer & Chief Financial Officer Jason Pesterfield, Veteran Med-Tech Executive and Growth Strategist, Named President, and CEO Kirk G. Jacquay, Seasoned Finance & Operations Leader, Named CFO EDEN PRAIRIE, Minn., June 29, 2023 ...

First in Minnesota: Park Nicollet Methodist Hospital Incorporates New State-of-the-Art Breast Cancer Treatment SAINT LOUIS PARK, Minn., April 13, 2023 (GLOBE NEWSWIRE) -- Park Nicollet Methodist Hospital is the first in the state to use Elucent’s EnVisio™ Surgical Navigation System and SmartClip™ technology....